Literature DB >> 10210370

Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis.

T Yagisawa1, P S Chandhoke, J Fan.   

Abstract

PURPOSE: We compared diagnostic information from limited and comprehensive metabolic evaluations of recurrent calcium stone formers.
MATERIALS AND METHODS: A total of 74 men and 45 women with recurrent calcium stones underwent comprehensive metabolic evaluation. The number of specific and total metabolic abnormalities diagnosed on 1 or 2 random 24-hour urinalyses were compared to those obtained on a comprehensive metabolic evaluation. We also examined the ability of the comprehensive evaluation to detect dietary calcium sensitive oxaluria.
RESULTS: The comprehensive metabolic evaluation yielded a specific metabolic diagnosis in 90% of the patients compared to 68% for 1 and 75% for 2 urinalyses. Average total number of specific metabolic abnormalities for each patient was approximately 50% higher on a comprehensive metabolic evaluation compared to 1 urinalysis (1.59 +/- 0.08 versus 0.94 +/- 0.07, p <0.05). Hypercalciuria, hyperoxaluria and hypocitruria were diagnosed significantly more often by the comprehensive than by the limited evaluation. Type II absorptive hypercalciuria was the most common pattern of hypercalciuria, and dietary calcium sensitive oxaluria was present in 22% of the patients.
CONCLUSIONS: Comprehensive metabolic evaluation yields significantly more useful diagnostic information and allows implementation of a more specific therapeutic plan than limited metabolic evaluation for the recurrent calcium stone former.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10210370

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinic.

Authors:  Madhur Nayan; Mohamed A Elkoushy; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

2.  Evaluation and medical management of the kidney stone patient.

Authors:  Ryan Paterson; Alfonso Fernandez; Hassan Razvi; Roger Sutton
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

3.  Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines.

Authors:  Yang Wang; Chun Sun; Chengyang Li; Yaoliang Deng; Guohua Zeng; Zhiwei Tao; Xiang Wang; Xiaofeng Guan; Yutong Zhao
Journal:  Urolithiasis       Date:  2016-07-08       Impact factor: 3.436

4.  Etiologic risk factors and vitamin D receptor gene polymorphisms in under one-year-old infants with urolithiasis.

Authors:  Ezgi Yangın Ergon; İpek Ozunan Akil; Fatma Taneli; Arzu Oran; Beyhan Cengız Ozyurt
Journal:  Urolithiasis       Date:  2017-10-30       Impact factor: 3.436

5.  Preservation of urine samples for metabolic evaluation of stone-forming patients.

Authors:  Renato Ribeiro Nogueira Ferraz; Alessandra Calábria Baxmann; Larissa Gorayb Ferreira; José Luiz Nishiura; Priscila Reina Siliano; Samirah Abreu Gomes; Silvia Regina Silva Moreira; Ita Pfeferman Heilberg
Journal:  Urol Res       Date:  2006-08-04

6.  Chitosan does not reduce post-prandial urinary oxalate excretion.

Authors:  Joshua Wolf; John R Asplin; David S Goldfarb
Journal:  Urol Res       Date:  2006-02-28

7.  International comparison of cost effectiveness of medical management strategies for nephrolithiasis.

Authors:  Yair Lotan; Jeffrey A Cadeddu; Margaret S Pearle
Journal:  Urol Res       Date:  2005-05-28

Review 8.  Metabolic evaluation of urinary lithiasis: what urologists should know and do.

Authors:  Julien Letendre; Jonathan Cloutier; Luca Villa; Luc Valiquette
Journal:  World J Urol       Date:  2014-11-21       Impact factor: 4.226

Review 9.  Nutrition and Kidney Stone Disease.

Authors:  Roswitha Siener
Journal:  Nutrients       Date:  2021-06-03       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.